Plus: low carb diets; oral insulin
Tuesday, Oct. 6, 2020 : Issue #1069 SPECIAL FEATURE - AI & the Future of Diabetes Management
Innovative Artificial Intelligence (AI) Tool Optimizes Care for T2D Patients
- Part 1 in a three part series |
|
Letter from the Editor
If you pick up any technology related medical journal or magazine, you can’t go more than a dozen pages before you find the first article or study about the use of AI (artificial intelligence). It seems that almost every medical specialty is taking advantage of the billions of split second evaluations that technology can make on behalf of medical professionals for their patients. AI can do everything for us if we give the technology a chance. A good example of this use of AI is the ability of insulin pumps to predict blood glucose 2 to 3 hours ahead, and adjust insulin accordingly.
This week, we are going to begin our presentation on the use of AI and the future of diabetes management. This is not a pie in the sky study; this is a real world look at a real program that incorporates the best care possible with realistic goals and medicine combinations, and even looks at what is covered on any person’s insurance and their financial standing to make sure they can adhere to the recommended medication and food regimens.
Click here to see Part 1 of the future of managing diabetes.
Note: "The Future of Type 2 Diabetes Management and The Changing Roles of Healthcare Professionals," will be presented in three parts. The series is about how a team of physicians and pharmacists at St. Elizabeth Healthcare in Kentucky uses artificial intelligence to improve treatment, adherence, and cost savings for both Medicaid and Americans, and to get the patient to goal in a shorter period.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
SPECIAL FEATURE: AI & the Future of Diabetes Management |
|
| Innovative Artificial Intelligence (AI) Tool Optimizes Care for T2D Patients
A new clinical software using artificial intelligence is being used for those with type 2 diabetes in Kentucky. It shows promising results in improving the Quality of Life for its residents and lowering treatment costs. This feature will be a 3-part series.
In Part 1: Adherence-related issues are hemorrhaging the costs of diabetes-related treatment in America. To offset this tragedy, GlucosePATH is utilized by a team of healthcare professionals dedicated to improving the quality of life while decreasing avoidable costs. |
| |
|
|
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
